Volume 16, Number 7—July 2010
Research
Zoonotic Transmission of Avian Influenza Virus (H5N1), Egypt, 2006–2009
Table 4
Characteristic | Total no. | No. died | CFR, % |
---|---|---|---|
Sex† | |||
F | 40 | 21 | 52.5 |
M |
23 |
3 |
13 |
Age group, y‡ | |||
0–4 | 23 | 0 | 0 |
5–14 | 11 | 2 | 18 |
15–49 | 27 | 20 | 74 |
>50 | 2 | 2 | 100 |
All ages |
63 |
24 |
38 |
Days between illness onset and hospitalization§ | |||
0–2 | 32 | 4 | 12.5 |
3–4 | 12 | 4 | 33 |
5–6 | 9 | 8 | 89 |
>7 |
9 |
8 |
89 |
Days between illness onset and first oseltamivir dose¶ | |||
0–2 | 25 | 1 | 4 |
3–4 | 14 | 3 | 21 |
5–6 | 7 | 5 | 71 |
>7 | 12 | 11 | 92 |
*CFR, case-fatality rate.
†p = 0.0004, by χ2 test for CFR for female patients vs. that for male patients.
‡p<0.001, by χ2 test for patients <15 years of age vs. patients >15 years of age.
§p<0.001, by χ2 test for patients hospitalized <2 d after illness onset vs. patients hospitalized after 2 d.
¶p<0.001, by χ2 test for patients who received oseltamivir <2 d after illness onset vs. patients who received oseltamivir after 2 d.
Page created: March 02, 2011
Page updated: March 02, 2011
Page reviewed: March 02, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.